Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID‐19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial
暂无分享,去创建一个
V. Jha | S. Myatra | S. Jakob | B. Vijayaraghavan | N. Andersen-Ranberg | A. Perner | M. Møller | L. Cioccari | A. Granholm | M. W. Munch | B. Venkatesh | Rebecka Wahlin Rubenson